SpectrumX appoints formulation chemist to lead product design and development of new cosmetics line

London – SpectrumX, a UK-based healthcare and pharmaceutical company, today announces an integral addition to its technical team, with the appointment of Emma McCance as formulation chemist. Reporting to Annaliese Waite, technical manager, McCance will be responsible for developing and optimising product formulations, a key step in bringing SpectrumX’s new cosmetics line to market. The […]

SpectrumX to provide full-service infection prevention solution to healthcare facilities 

Damien Hancox, CEO, announces partnerships with industry-leading healthcare specialists Ophardt Hygiene and SureWash for hand hygiene programme London – SpectrumX, a UK-based healthcare and pharmaceutical company, today announces that it now offers a full-service infection prevention solution to hospitals and healthcare facilities through new partnerships with healthcare specialists SureWash and Ophardt Hygiene. The hand hygiene […]

SpectrumX Expands into UK’s South East Region

Industry expert, Samantha Gibbons, appointed to newly created post of UK’s Regional Account Manager, South East London – SpectrumX, a UK-based healthcare and pharmaceutical company, is pleased to announce the appointment of Samantha Gibbons to the newly created post of UK’s Regional Account Manager, South East. This addition to the sales team comes as SpectrumX […]

SpectrumX Expands into North East of England and Scotland

London – SpectrumX, a UK-based healthcare and pharmaceutical company, today announces the appointment of Sarah Ewart to the newly created post of UK’s Regional Account Manager, North East and Scotland. This addition to the sales team comes as SpectrumX brings its novel Spectricept product line of broad-spectrum, non-skin-irritant disinfectants to market and supports the Company’s […]

SpectrumX adds financial controller to management team

Damien Hancox, CEO, describes hire of life sciences sector finance and accounting expert as an important addition, as the Company grows its commercial offerings London – SpectrumX, a UK-based healthcare and pharmaceutical company, today announces the appointment of Scott Grant as financial controller. Grant joins SpectrumX’s finance team – led by CFO Barry Saint – […]

SpectrumX confirms next step in clinical development of respiratory drug candidate SPX-001 after MHRA meeting

CEO Damien Hancox outlines next step after constructive scientific advice meeting with regulatory agency London – SpectrumX, a UK-based healthcare and pharmaceutical company, today announces that following a constructive scientific advice meeting with the Medicines and Healthcare products Regulatory Agency (MHRA) on Monday, 14th November, the Company is prepared to move forward with the next […]

SpectrumX announces appointment of new regional account manager, UK South West

CEO Damien Hancox describes hire as key milestone in accelerating sales programme for Company’s novel Spectricept product line London – SpectrumX, a UK-based healthcare and pharmaceutical company, today announces the appointment of Sheena Powell as regional account manager, UK South West, to its growing sales team. The move comes as CEO Damien Hancox and the […]

SpectrumX launches revolutionary sporicidal body wash for healthcare facilities

Spectricept HLD Body MIST is a proven skin-safe sporicidal disinfectant wash, effective against a broad spectrum of pathogens, including Clostridiosides difficile (C. difficile) spores, the bacteria that causes potentially life-threatening gastrointestinal infections common in healthcare settings After two minutes of contact time, Spectricept eradicates all C. difficile spores on the skin’s surface, making it more […]

SpectrumX reaches partnership agreement on human volunteer study for ground-breaking respiratory infection drug candidate SPX-001

Start-up agreement is major step forward in readiness to conduct Phase 1b clinical trial of Company’s HOCl-based respiratory infection drug candidate, SPX-001 Start-up agreement is major step forward in readiness to conduct Phase 1b clinical trial of Company’s HOCl-based respiratory infection drug candidate, SPX-001 Partner and SpectrumX will align on detailed clinical trial protocol to […]